tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CLNN Stock Latest News

Clene management to meet with Maxim
The FlyClene management to meet with Maxim
4d ago
CLNN
Clene Approves Stock Plan Amendment at Annual Meeting
PremiumCompany Announcements
Clene Approves Stock Plan Amendment at Annual Meeting
15d ago
8K
CLNN
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures
PremiumCompany Announcements
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures
30d ago
CLNN
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating
PremiumRatings
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating
1M ago
CLNN
Clene’s Strategic Focus and Promising CNM-Au8 Developments Drive Buy Rating
PremiumRatings
Clene’s Strategic Focus and Promising CNM-Au8 Developments Drive Buy Rating
1M ago
CLNN
Clene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits
PremiumCompany AnnouncementsClene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits
1M ago
8K
CLNN
Clene reports Q1 EPS (9c), consensus (78c)
Premium
The Fly
Clene reports Q1 EPS (9c), consensus (78c)
1M ago
CLNN
Clene sees cash runway into 3Q25
Premium
The Fly
Clene sees cash runway into 3Q25
1M ago
CLNN
Optimistic Outlook on Clene’s CNM-Au8 for ALS: Investment Potential Amid Clinical Challenges
PremiumRatings
Optimistic Outlook on Clene’s CNM-Au8 for ALS: Investment Potential Amid Clinical Challenges
2M ago
CLNN
Clene initiated with a Buy at JonesResearch
PremiumThe Fly
Clene initiated with a Buy at JonesResearch
2M ago
CLNN
Promising Potential of Clene’s CNM-Au8 in MS: Analyst Recommends Buy Rating
PremiumRatings
Promising Potential of Clene’s CNM-Au8 in MS: Analyst Recommends Buy Rating
2M ago
CLNN
Clene Showcases CNM-Au8® Advancements at Neurology Session
PremiumCompany Announcements
Clene Showcases CNM-Au8® Advancements at Neurology Session
2M ago
8K
CLNN
Clene announces evidence of remyelination, neuronal repair with CNM-Au8
PremiumThe FlyClene announces evidence of remyelination, neuronal repair with CNM-Au8
2M ago
CLNN
Clene’s Strategic Advancements and Financial Position Reinforce Buy Rating for CNM-Au8’s Promising Future
Premium
Ratings
Clene’s Strategic Advancements and Financial Position Reinforce Buy Rating for CNM-Au8’s Promising Future
2M ago
CLNN
Clene files $160M mixed securities shelf
Premium
The Fly
Clene files $160M mixed securities shelf
2M ago
CLNN
Clene Inc. Reports 2024 Financial Results and Strategic Plans
PremiumCompany Announcements
Clene Inc. Reports 2024 Financial Results and Strategic Plans
2M ago
CLNN
Clene’s Strategic Advancements and Promising Data Drive Buy Rating for ALS Treatment
PremiumRatings
Clene’s Strategic Advancements and Promising Data Drive Buy Rating for ALS Treatment
3M ago
CLNN
Clene reports FY24 EPS ($5.67), consensus ($4.48)
PremiumThe Fly
Clene reports FY24 EPS ($5.67), consensus ($4.48)
3M ago
CLNN
Clene sees cash runway into 2Q25
PremiumThe Fly
Clene sees cash runway into 2Q25
3M ago
CLNN
Promising Potential of Clene’s CNM-Au8 for ALS Drives Buy Rating
PremiumRatingsPromising Potential of Clene’s CNM-Au8 for ALS Drives Buy Rating
3M ago
CLNN
Clene announces evidence from post-hoc analysis of HEALY ALS platform trial
Premium
The Fly
Clene announces evidence from post-hoc analysis of HEALY ALS platform trial
3M ago
CLNN
Strategic Advancements and Regulatory Progress Bolster Clene’s ALS Treatment Outlook
Premium
Ratings
Strategic Advancements and Regulatory Progress Bolster Clene’s ALS Treatment Outlook
3M ago
CLNN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >